BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5887 related articles for article (PubMed ID: 3101284)

  • 1. Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas.
    Ralfkiaer E; Hou-Jensen K; Gatter KC; Drzewiecki KT; Mason DY
    Virchows Arch A Pathol Anat Histopathol; 1987; 410(4):355-61. PubMed ID: 3101284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photosensitive dermatitis with actinic reticuloid syndrome: an immunohistological study of the cutaneous infiltrate.
    Ralfkiaer E; Wantzin GL; Stein H; Mason DY
    Br J Dermatol; 1986 Jan; 114(1):47-56. PubMed ID: 3510653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.
    Bröcker EB; Zwadlo G; Holzmann B; Macher E; Sorg C
    Int J Cancer; 1988 Apr; 41(4):562-7. PubMed ID: 3128489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies.
    Ralfkiaer E; Stein H; Wantzin GL; Thomsen K; Ralfkiaer N; Mason DY
    Am J Clin Pathol; 1985 Nov; 84(5):587-93. PubMed ID: 3904400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression.
    Brogelli L; Moretti S; Borgognoni L; Giannotti B
    Dermatologica; 1990; 180(2):69-72. PubMed ID: 2311798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign and malignant lymphocytic skin infiltrates: immunological patterns recognized by immunohistochemical staining with monoclonal antibodies.
    Ralfkiaer E; Hou-Jensen K; Mason DY; Stein H; Wantzin GL; Thomsen K
    Adv Exp Med Biol; 1985; 186():1033-41. PubMed ID: 3876696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma.
    Hersey P; Murray E; Grace J; McCarthy WH
    Pathology; 1985 Jul; 17(3):385-91. PubMed ID: 2866482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas.
    García-Plata D; Lessana-Leibowitch M; Palangie A; Gulliemette J; Sedel D; Méndez L; Mozos E
    Invasion Metastasis; 1995; 15(3-4):125-34. PubMed ID: 8621268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies.
    Ralfkiaer E; Lange Wantzin G; Mason DY; Stein H; Thomsen K
    Br J Dermatol; 1984 Dec; 111(6):635-45. PubMed ID: 6391533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of epidermal Langerhans cells and dermal dendritic cells in benign and malignant skin lesions characterized by a dermal lymphoid infiltrate consisting either of B-cells or T-cells.
    Drijkoningen M; De Wolf-Peeters C; Snauwaert J; De Greef H; Desmet V
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):337-43. PubMed ID: 2442885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential immunophenotypic study of lymphoid infiltrate in allergic and irritant reactions.
    Avnstorp C; Ralfkiaer E; Jørgensen J; Wantzin GL
    Contact Dermatitis; 1987 May; 16(5):239-45. PubMed ID: 3497775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigen expression in primary melanomas of the skin.
    Bröcker EB; Suter L; Sorg C
    J Invest Dermatol; 1984 Mar; 82(3):244-7. PubMed ID: 6366074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells in various benign and malignant pigment-cell lesions of the skin.
    Facchetti F; de Wolf-Peeters C; de Greef H; Desmet VJ
    Arch Dermatol Res; 1984; 276(5):283-7. PubMed ID: 6237618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological study of mononuclear cell infiltrate in malignant gliomas.
    Rossi ML; Hughes JT; Esiri MM; Coakham HB; Brownell DB
    Acta Neuropathol; 1987; 74(3):269-77. PubMed ID: 3314311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical staining of T and B lymphocytes in serous effusions.
    Ghosh AK; Spriggs AI; Mason DY
    J Clin Pathol; 1985 Jun; 38(6):608-12. PubMed ID: 3891789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets and Langerhans cells in skin tumours.
    Fernandez-Bussy R; Cambazard F; Mauduit G; Schmitt D; Thivolet J
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):907-13. PubMed ID: 6603978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of tumor cells and inflammatory infiltrate associated with cutaneous melanocytic tumors of Duroc and Iberian swine.
    Perez J; García PM; Bautista MJ; Millán Y; Ordás J; Martín de las Mulas J
    Vet Pathol; 2002 Jul; 39(4):445-51. PubMed ID: 12126147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 295.